These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8191194

  • 1. [The use of capillary videomicroscopy in the therapeutic assessment of acral vasospastic phenomena: microcirculatory effect of ketanserin and nifedipine].
    Gasser P.
    Schweiz Rundsch Med Prax; 1994 Apr 26; 83(17):511-4. PubMed ID: 8191194
    [Abstract] [Full Text] [Related]

  • 2. Reaction of capillary blood cell velocity in nailfold capillaries to nifedipine and ketanserin in patients with vasospastic disease.
    Gasser P.
    J Int Med Res; 1991 Apr 26; 19(1):24-31. PubMed ID: 2019313
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon.
    Codella O, Caramaschi P, Olivieri O, Perbellini L, Perbellini A, Bambara LM, Corrocher R, De Sandre G.
    Angiology; 1989 Feb 26; 40(2):114-21. PubMed ID: 2644876
    [Abstract] [Full Text] [Related]

  • 5. [Capillaroscopy and Raynaud's phenomenon].
    Carpentier P, Franco A.
    J Mal Vasc; 1984 Feb 26; 9(1):23-8. PubMed ID: 6707531
    [Abstract] [Full Text] [Related]

  • 6. [Ocular vasospasm. 2: Diagnosis of vasospastic syndrome using nailfold capillary videomicroscopy].
    Gasser P, Prünte-Glowazki A.
    Klin Monbl Augenheilkd; 1991 May 26; 198(5):412-3. PubMed ID: 1886372
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Microcirculatory changes in patients with primary Raynaud's phenomenon after treatment with buflomedil.
    Jacobs MJ, Lemmens HA.
    Int J Microcirc Clin Exp; 1985 May 26; 4(1):63-8. PubMed ID: 3886577
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of nifedipine in Raynaud's disease: a case report.
    Maguire FW.
    Del Med J; 1984 Jul 26; 56(7):393-8. PubMed ID: 6479385
    [No Abstract] [Full Text] [Related]

  • 18. Raynaud's phenomenon and nifedipine.
    Kraus A.
    J Rheumatol; 1989 Jul 26; 16(7):1013. PubMed ID: 2597264
    [No Abstract] [Full Text] [Related]

  • 19. [Practical importance of capillary microscopy].
    Saner H, Bollinger A, Mahler F.
    Schweiz Med Wochenschr; 1988 Nov 05; 118(44):1622-7. PubMed ID: 3238398
    [Abstract] [Full Text] [Related]

  • 20. Antioxidant agents help primary Raynaud's phenomenon.
    Bruni C, Lepri G, Peruzzi F, Bellando-Randone S, Radicati A, Matucci-Cerinic M, Guiducci S.
    Int Angiol; 2015 Feb 05; 34(1):94-5. PubMed ID: 24732584
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.